NSCLC cells express EGFR and its derivatives, which play a key role in the pathogenesis of lung cancer [33], and therefore, the cell blockade of the EGFR signaling represents a promising cancer treatment strategy. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.